+

EP1165591A4 - 47 proteines humaines secretees - Google Patents

47 proteines humaines secretees

Info

Publication number
EP1165591A4
EP1165591A4 EP00916590A EP00916590A EP1165591A4 EP 1165591 A4 EP1165591 A4 EP 1165591A4 EP 00916590 A EP00916590 A EP 00916590A EP 00916590 A EP00916590 A EP 00916590A EP 1165591 A4 EP1165591 A4 EP 1165591A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00916590A
Other languages
German (de)
English (en)
Other versions
EP1165591A1 (fr
Inventor
Craig A Rosen
Steven M Ruben
George Komatsoulis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1165591A1 publication Critical patent/EP1165591A1/fr
Publication of EP1165591A4 publication Critical patent/EP1165591A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP00916590A 1999-03-26 2000-03-22 47 proteines humaines secretees Withdrawn EP1165591A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12659899P 1999-03-26 1999-03-26
US126598P 1999-03-26
US17150499P 1999-12-22 1999-12-22
US171504P 1999-12-22
PCT/US2000/007534 WO2000058335A1 (fr) 1999-03-26 2000-03-22 47 proteines humaines secretees

Publications (2)

Publication Number Publication Date
EP1165591A1 EP1165591A1 (fr) 2002-01-02
EP1165591A4 true EP1165591A4 (fr) 2002-09-25

Family

ID=26824847

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00916590A Withdrawn EP1165591A4 (fr) 1999-03-26 2000-03-22 47 proteines humaines secretees

Country Status (5)

Country Link
EP (1) EP1165591A4 (fr)
JP (1) JP2002539815A (fr)
AU (1) AU3767300A (fr)
CA (1) CA2368374A1 (fr)
WO (1) WO2000058335A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062926A2 (fr) * 2000-02-25 2001-08-30 Millennium Pharmaceuticals, Inc. Molecules 44576, nouveau recepteur couple a la proteine g et utilisation de celui-ci
US7939497B2 (en) * 2002-03-08 2011-05-10 Shanghai Institutes For Biological Sciences, Cas Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof
AU2004293502B2 (en) * 2003-11-28 2010-12-02 National Research Council Of Canada Anticarcinoma antibodies and uses thereof
JP5891561B2 (ja) * 2011-06-03 2016-03-23 学校法人自治医科大学 ミトコンドリア膜タンパク質群およびそれらをコードする遺伝子群

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792628A (en) * 1997-03-14 1998-08-11 Bowman; Michael Secreted protein, BA3.1, and polynucleotides encoding same
WO1998046756A1 (fr) * 1997-04-16 1998-10-22 Millennium Biotherapeutics Compositions de proteines secretees ssp-1 et utilisations de ces compositions a des fins diagnostiques et therapeutiques
EP0879887A1 (fr) * 1997-05-21 1998-11-25 Smithkline Beecham Corporation Un gène humain ressemblant à la protéine murine secretée SDF5 (ATG-1622)
WO1999047540A1 (fr) * 1998-03-19 1999-09-23 Human Genome Sciences, Inc. 95 proteines humaines secretees
WO2000027994A2 (fr) * 1998-11-12 2000-05-18 The Regents Of The University Of California Sequence genomique de chlamydia pneumoniae
WO2000055173A1 (fr) * 1999-03-12 2000-09-21 Human Genome Sciences, Inc. Sequences et polypeptides geniques associes au cancer des ovaires et du sein

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792628A (en) * 1997-03-14 1998-08-11 Bowman; Michael Secreted protein, BA3.1, and polynucleotides encoding same
WO1998046756A1 (fr) * 1997-04-16 1998-10-22 Millennium Biotherapeutics Compositions de proteines secretees ssp-1 et utilisations de ces compositions a des fins diagnostiques et therapeutiques
EP0879887A1 (fr) * 1997-05-21 1998-11-25 Smithkline Beecham Corporation Un gène humain ressemblant à la protéine murine secretée SDF5 (ATG-1622)
WO1999047540A1 (fr) * 1998-03-19 1999-09-23 Human Genome Sciences, Inc. 95 proteines humaines secretees
WO2000027994A2 (fr) * 1998-11-12 2000-05-18 The Regents Of The University Of California Sequence genomique de chlamydia pneumoniae
WO2000055173A1 (fr) * 1999-03-12 2000-09-21 Human Genome Sciences, Inc. Sequences et polypeptides geniques associes au cancer des ovaires et du sein

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 1 February 2000 (2000-02-01), XP002197011 *
DATABASE EMBL 14 September 1999 (1999-09-14), XP002197012 *
DATABASE EMBL 2 November 1999 (1999-11-02), XP002197010 *
DATABASE EMBL 27 April 1999 (1999-04-27), XP002197009 *
DATABASE EMBL 6 January 1999 (1999-01-06), XP002197005 *
DATABASE EMBL 7 June 1997 (1997-06-07), XP002197004 *
DATABASE SWISSPROT 1 February 1994 (1994-02-01), XP002197008 *
DATABASE SWISSPROT 1 November 1996 (1996-11-01), XP002197006 *
DATABASE SWISSPROT 15 December 1998 (1998-12-15), XP002197007 *
See also references of WO0058335A1 *

Also Published As

Publication number Publication date
WO2000058335A1 (fr) 2000-10-05
EP1165591A1 (fr) 2002-01-02
JP2002539815A (ja) 2002-11-26
AU3767300A (en) 2000-10-16
CA2368374A1 (fr) 2000-10-05

Similar Documents

Publication Publication Date Title
EP1218408A4 (fr) 32 proteines humaines secretees
EP1212343A4 (fr) 52 proteines humaines secretees
EP1181390A4 (fr) 27 proteines humaines secretees
EP1234030A4 (fr) 18 proteines secretees humaines
EP1224285A4 (fr) 27 proteines humaines secretees
EP1212342A4 (fr) 18 proteines secretees humaines
EP1226231A4 (fr) 19 proteines humaines secretees
EP1175438A4 (fr) Soixante-deux prot ines humaines s cr t es
EP1192176A4 (fr) 49 proteines secretees humaines
EP1192278A4 (fr) 48 proteines secretees humaines
EP1165827A4 (fr) 45 proteines humaines secretees
EP1175439A4 (fr) 49 proteines humaines secretees
EP1159284A4 (fr) 33 proteines humaines secretees
EP1189917A4 (fr) 48 proteines humaines secretees
EP1185543A4 (fr) 50 proteines humaines secretees
EP1203005A4 (fr) 25 proteines secretees humaines
EP1173477A4 (fr) 49 proteines humaines secretees
EP1224201A4 (fr) 32 proteines humaines secretees
EP1206573A4 (fr) 26 proteines humaines secretees
EP1169332A4 (fr) Proteines humaines secretees (49)
EP1144614A4 (fr) Proteines humaines secretees (33)
EP1171460A4 (fr) 48 proteines secretees humaines
EP1165602A4 (fr) 49 proteines secretees par un etre humain
EP1165828A4 (fr) 50 proteines humaines secretees
EP1228082A4 (fr) Proteines humaines secretees 29

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010927

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HUMAN GENOME SCIENCES, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20020808

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030715

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041014

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载